Cancer Research Cancer Treatment Chemotherapy Cancer Cancer Biology Cancer Types Patient Care Lung Cancer Cancer Survivorship Brain Tumors
Oncolytic HSV-1 with nivolumab triggered tumor shrinkage or disappearance throughout the body in patients who had not responded to existing immunotherapies.